Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

801
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
801
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

258
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

216
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
216
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

359
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
359
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

319
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
319
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

301
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
301

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mentoring the future of neonatology: program director advice for fellowship applicants and their advisors.

Journal of perinatology : official journal of the California Perinatal Association·2025
Same author

Machine-Learning Model Identifies Patients With Alpha-1 Antitrypsin Deficiency Using Claims Records.

COPD·2024
Same author

Learning to Identify Rare Disease Patients from Electronic Health Records.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2019
Same author

Robust Ensemble Learning to Identify Rare Disease Patients from Electronic Health Records.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2018
Same author

Ensemble transfer learning for Alzheimer's disease diagnosis.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017
Same author

Learning about individuals' health from aggregate data.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2017

Related Experiment Video

Updated: Feb 2, 2026

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
14:14

The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

Published on: May 13, 2022

6.4K

Early Identification of Patentable Medical Innovations.

Rich Colbaugh, Kristin Glass

    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
    |November 17, 2018
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel machine learning model for the early identification of patentable medical innovations. This computational approach aids in detecting promising medical advances for future treatments.

    More Related Videos

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
    10:43

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices

    Published on: November 5, 2016

    9.5K
    Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
    10:52

    Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

    Published on: December 23, 2022

    5.9K

    Related Experiment Videos

    Last Updated: Feb 2, 2026

    The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups
    14:14

    The Innovation Arena: A Method for Comparing Innovative Problem-Solving Across Groups

    Published on: May 13, 2022

    6.4K
    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices
    10:43

    High-throughput Identification of Bacteria Repellent Polymers for Medical Devices

    Published on: November 5, 2016

    9.5K
    Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
    10:52

    Closure of a Patent Foramen Ovale PFO: An Intervention Sequence

    Published on: December 23, 2022

    5.9K

    Area of Science:

    • Biomedical informatics
    • Computational science
    • Intellectual property management

    Background:

    • Early detection of significant medical advances is crucial for developing effective treatments.
    • The sheer volume of annual discoveries necessitates computational methods for practical identification.
    • Identifying patentable innovations is a key step in this early detection process.

    Purpose of the Study:

    • To present a novel machine learning-based prediction model.
    • To enable the early identification of patentable innovations within medical research.
    • To support the detection of medical advances with potential for effective treatments.

    Main Methods:

    • Development of a machine learning prediction model.
    • Application of the model to identify patentable innovations.
    • Experimental validation of the model's efficacy.

    Main Results:

    • The proposed machine learning model effectively identifies patentable innovations.
    • Experimental results demonstrate the practical utility of the approach.
    • The model shows promise in the early detection of significant medical advances.

    Conclusions:

    • The developed machine learning model is effective for early identification of patentable medical innovations.
    • This computational approach can significantly aid in detecting promising medical advances.
    • The findings support the use of machine learning in accelerating therapeutic development.